L, D., J, Z., F, Z., B, L., Z, X., H, Z., . . . J, J. (2021). Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]. Dove Medical Press.
Chicago Style (17th ed.) CitationL, Duan, Zuo J, Zhang F, Li B, Xu Z, Zhang H, Yang B, Song W, and Jiang J. Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]. Dove Medical Press, 2021.
MLA (8th ed.) CitationL, Duan, et al. Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.